Bibliometric and visual analysis of cardiovascular diseases and Covid-19 research
Bibliographic Data
Background The global community has been affected by the coronavirus disease 2019 (COVID-19), which emerged in December 2019. Since then, many studies have been conducted on cardiovascular diseases (CVDs) and COVID-19. The aim of this study was to perform a bibliometric and visual analysis of the published relationship between CVDs and COVID-19. Methods 1,890 publications were retrieved from the Web of Science Core Collection database on January 5, 2022. Microsoft Office Excel and CiteSpace were then used to carry out scientometric analysis on the relevant literature according to seven aspects: document type, countries/regions, institutions, authors, journals, references, and keywords. Results The research on CVDs and COVID-19 is currently in a period of rapid development, with China, USA, England, and Italy leading the field. There is active cooperation between most countries and institutions. Harvard Medical School stands out among the many institutions not only for the largest number of publications, but also for their high quality. Banerjee A, Solomon SD and Narula J are three representative authors in this field. Frontiers in Cardiovascular Medicine was the journal with the highest number of published studies, and The Lancet was the most cited journal. Two documents with a high degree of significance in this field were identified. Popular research topics in this field are specific diseases, such as acute coronary syndrome and heart failure; pathogenesis related to ACE2, insulin resistance and pericyte; the specific therapeutic drug chloroquine; and clinical characteristics, physical activity, and mental health. ACE2 and NF-κB will be the focus of future research. Conclusions This study provides useful information for the research of CVDs and COVID-19, including potential collaborators, popular research topics, and a reference for more extensive and in-depth research in the future
Bibliometrics · China · Disease · Family medicine · Library science · Pandemic · Pathology · Political science · Computer Science · COVID-19 Clinical Research Studies · Diverse Scientific Research Studies · Medicine · Pharmacological Receptor Mechanisms and Effects
Why does Covid-19 disproportionately affect older people?
Searching for intellectual turning points
Mental health consequences during the initial stage of the 2020 Coronavirus pandemic (Covid-19) in Spain
Clinical course and outcomes of critically ill patients with Sars-CoV-2 pneumonia in Wuhan, China
Global, regional, and national estimates of the population at increased risk of severe Covid-19 due to underlying health conditions in 2020
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
A novel coronavirus outbreak of global health concern
Emerging trends in regenerative medicine
The Nuclear Factor NF- B Pathway in Inflammation
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With Covid-19 in the New York City Area
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
CiteSpace II
Sars-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Constructing bibliometric networks
Co‐citation in the scientific literature
Clinical Characteristics of Coronavirus Disease 2019 in China
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Clinical course and risk factors for mortality of adult inpatients with Covid-19 in Wuhan, China
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (Covid-19) Outbreak in China
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Software survey
| Highly cited | No |
|---|